BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 34987649)

  • 21. Chitinase 3-like 1 secreted by peritumoral macrophages in esophageal squamous cell carcinoma is a favorable prognostic factor for survival.
    Xing S; Zheng X; Zeng T; Zeng MS; Zhong Q; Cao YS; Pan KL; Wei C; Hou F; Liu WL
    World J Gastroenterol; 2017 Nov; 23(43):7693-7704. PubMed ID: 29209110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 23. The GTPase Rab37 Participates in the Control of Insulin Exocytosis.
    Ljubicic S; Bezzi P; Brajkovic S; Nesca V; Guay C; Ohbayashi N; Fukuda M; Abderrhamani A; Regazzi R
    PLoS One; 2013; 8(6):e68255. PubMed ID: 23826383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
    Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
    J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CHI3L1 regulates PD-L1 and anti-CHI3L1-PD-1 antibody elicits synergistic antitumor responses.
    Ma B; Akosman B; Kamle S; Lee CM; He CH; Koo JS; Lee CG; Elias JA
    J Clin Invest; 2021 Nov; 131(21):. PubMed ID: 34720089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chitinase-3-Like-1 Promotes M2 Macrophage Differentiation and Induces Choroidal Neovascularization in Neovascular Age-Related Macular Degeneration.
    Xu N; Bo Q; Shao R; Liang J; Zhai Y; Yang S; Wang F; Sun X
    Invest Ophthalmol Vis Sci; 2019 Nov; 60(14):4596-4605. PubMed ID: 31675076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphorylation of Rab37 by protein kinase C alpha inhibits the exocytosis function and metastasis suppression activity of Rab37.
    Tzeng HT; Li TH; Tang YA; Tsai CH; Frank Lu PJ; Lai WW; Chiang CW; Wang YC
    Oncotarget; 2017 Dec; 8(65):108556-108570. PubMed ID: 29312551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of the secretory small GTPase Rab27B on breast cancer growth, invasion, and metastasis.
    Hendrix A; Maynard D; Pauwels P; Braems G; Denys H; Van den Broecke R; Lambert J; Van Belle S; Cocquyt V; Gespach C; Bracke M; Seabra MC; Gahl WA; De Wever O; Westbroek W
    J Natl Cancer Inst; 2010 Jun; 102(12):866-80. PubMed ID: 20484105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fully human chitinase-3 like-1 monoclonal antibody inhibits tumor growth, fibrosis, angiogenesis, and immune cell remodeling in lung, pancreatic, and colorectal cancers.
    Su PC; Chen CY; Yu MH; Kuo IY; Yang PS; Hsu CH; Hou YC; Hsieh HT; Chang CP; Shan YS; Wang YC
    Biomed Pharmacother; 2024 May; 176():116825. PubMed ID: 38820971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deletion of Chitinase-3-like 1 accelerates stroke development through enhancement of Neuroinflammation by STAT6-dependent M2 microglial inactivation in Chitinase-3-like 1 knockout mice.
    Im JH; Yeo IJ; Park PH; Choi DY; Han SB; Yun J; Hong JT
    Exp Neurol; 2020 Jan; 323():113082. PubMed ID: 31669069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chitinase 3-like-1, a novel regulator of Th1/CTL responses, as a therapeutic target for increasing anti-tumor immunity.
    Kim DH; Choi JM
    BMB Rep; 2018 May; 51(5):207-208. PubMed ID: 29699605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secretory autophagy promotes RAB37-mediated insulin secretion under glucose stimulation both
    Wu SY; Wu HT; Wang YC; Chang CJ; Shan YS; Wu SR; Chiu YC; Hsu CL; Juan HF; Lan KY; Chu CW; Lee YR; Lan SH; Liu HS
    Autophagy; 2023 Apr; 19(4):1239-1257. PubMed ID: 36109708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of metastasis through inhibition of chitinase 3-like 1 expression by miR-125a-3p-mediated up-regulation of USF1.
    Kim KC; Yun J; Son DJ; Kim JY; Jung JK; Choi JS; Kim YR; Song JK; Kim SY; Kang SK; Shin DH; Roh YS; Han SB; Hong JT
    Theranostics; 2018; 8(16):4409-4428. PubMed ID: 30214629
    [No Abstract]   [Full Text] [Related]  

  • 34. Potential Roles and Future Perspectives of Chitinase 3-like 1 in Macrophage Polarization and the Development of Diseases.
    Zhao H; Huang M; Jiang L
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paralysis of the cytotoxic granule machinery is a new cancer immune evasion mechanism mediated by chitinase 3-like-1.
    Darwich A; Silvestri A; Benmebarek MR; Mouriès J; Cadilha B; Melacarne A; Morelli L; Supino D; Taleb A; Obeck H; Sustmann C; Losurdo A; Masci G; Curigliano G; Kobold S; Penna G; Rescigno M
    J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34824159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of chitinase-3-like-1 in T cell elicits Th1 and cytotoxic responses to inhibit lung metastasis.
    Kim DH; Park HJ; Lim S; Koo JH; Lee HG; Choi JO; Oh JH; Ha SJ; Kang MJ; Lee CM; Lee CG; Elias JA; Choi JM
    Nat Commun; 2018 Feb; 9(1):503. PubMed ID: 29403003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccine against gastrin, a polyclonal antibody stimulator, decreases pancreatic cancer metastases.
    Osborne N; Sundseth R; Gay MD; Cao H; Tucker RD; Nadella S; Wang S; Liu X; Kroemer A; Sutton L; Cato A; Smith JP
    Am J Physiol Gastrointest Liver Physiol; 2019 Nov; 317(5):G682-G693. PubMed ID: 31433212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knockdown of Chitinase 3-Like-1 Inhibits Cell Proliferation, Promotes Apoptosis, and Enhances Effect of Anti-Programmed Death Ligand 1 (PD-L1) in Diffuse Large B Cell Lymphoma Cells.
    Yang X; Fang D; Li M; Chen J; Cheng Y; Luo J
    Med Sci Monit; 2021 Mar; 27():e929431. PubMed ID: 33764958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CHI3L1 results in poor outcome of ovarian cancer by promoting properties of stem-like cells.
    Lin HW; Chiang YC; Sun NY; Chen YL; Chang CF; Tai YJ; Chen CA; Cheng WF
    Endocr Relat Cancer; 2019 Jan; 26(1):73-88. PubMed ID: 30121622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chi3l1 regulates APAP-induced liver injury by promoting macrophage infiltration.
    Wang Y; Zhong M; Wang W; Li YH
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4996-5003. PubMed ID: 31210337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.